Heart Failure Consultant

Care Pathway Co-ordinator for Heart Failure New Patients queries: Carol Stechman

Email: Carol.Stechman@nhs.net

Telephone: 020 8725 2305


Professional profile

Dr Anderson achieved her BSc and MB ChB from Liverpool in 1987 and 1990 respectively. She obtained her MD from Imperial College in 2001 before completing cardiology specialist registrar training at St George's Hospital in 2005.

Dr Anderson was appointed consultant cardiologist in 2005 and was made honorary senior lecturer at St George's University of London in the same year. She has been heart failure lead for the South West London Cardiac and Stroke Network since 2006.

  • MRC Intercalated Fellowship
  • British Heart Foundation Junior Fellowship
  • Fellow: European Society of Cardiology
  • Member: Royal College of Physicians
  • Member: Society of Cardiovascular Magnetic Resonance
  • Member: Research Ethics Committee, Wandsworth

Clinical interests

Heart Failure and Cardiac Magnetic Resonance.

Dr Anderson trained on the London (SW) Cardiology rotation and completed Specialist training in August 2005 and was appointed Consultant Cardiologist in October 2001.

Dr Anderson was BHF Junior Research Fellow at the Royal Brompton Hospital Cardiac MR Unit from 1998 to 2001, developing a method (T2*) for early detection of cardiac iron that is now the International Gold Standard and has led to a significant fall in cardiac deaths in thalassaemia.

Dr Anderson has worked with GP colleagues and commissioners and St George’s Hospital to build up community and hospital heart failure services since 2005.

In 2016, the St Georges Heart Failure Unit opened, providing specialist nursing, therapist and cardiology care to admitted patients with heart failure. The purpose of this unit is to improve patient experience and outcomes, to better integrate acute with community care and to provide a centre of excellence in which to train heart failure nurses and fellows.

Dr Anderson was appointed as Councillor to the BSH Board in 2015 and is a member of the European HFA Study Group on Imaging.

Dr Anderson has ongoing research interests in Heart Failure and Cardiac Magnetic Resonance Imaging.


Dungu JN, Valencia O, Papadopoulou S, Mahmood I, Wykes K, Marshall J, Gilmore  JD, Hawkins PN, Lisa J Anderson LJ. Afro-Caribbean Heart Failure in the UK: Etiology, Outcomes and ATTR V122I Cardiac Amyloidosis. Circ Heart Fail. 2016;9:e003352 published September 12, 2016.

Dungu J, Valencia O, Pinney V, Gibbs S, Rowczenio D, Gilbertson J, Lachmann H, Wechalekar A, Gillmore J, Whelan C, Hawkins P, Anderson L. Cardiovascular magnetic resonance (CMR) for the differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:133-42.

Shanmugam N, Campos AG, Prada-Delgado O, Bizrah M, Valencia O, Jones S, Collinson P, Anderson L. Effect of atrioventricular optimization on circulating N-terminal pro-B-type natriuretic peptide following cardiac resynchronization therapy. Eur J Heart Fail. 2013;15:534-42.

Shanmugam N, Prada-Delgado O, Campos AG, Grimster A, Valencia O, Baltabaeva A, Jones S, Anderson L.Rate Adaptive AV delay and Exercise Performance following Cardiac Resynchronization Therapy.  Heart Rhythm. 2012:1815-21.

Dungu JJ, Sattianayagam PT, Whelan CJ, Gibbs SDJ, Pinney JH, Banypersad SM, Rowczenio D, Gilbertson JA, Lachmann HJ, Wechalekar A, Gillmore JD, MD, Hawkins PN, Anderson LJ. The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients. Am Heart J. 2012;164:72.

Dungu J, Anderson LJ, Whelan CJ, Hawkins PN. Cardiac Transthyretin Amyloidosis. Review. Heart. 2012;98:1546-54.

Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.Lancet 2002; 360:516-20.

Anderson LJ, Holden S, Davies B, Prescott E, Charrier C, Bunce NH, Firmin DN, Porter JB, Wonke B, Walker JM, Pennell DJ. Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-9.